Where Growth at a Good Price Lurks

Posted on February 23, 2004

Q: How about Johnson & Johnson (JNJ )?A: We like Johnson & Johnson at current levels. They have a great track record of growing sales and earnings at double-digit rates. The stock didn't participate in last year's rally. Negative news on their drug

Business Exchange: What your peers are reading.

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus